Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yoshihiko Kawaguchi is active.

Publication


Featured researches published by Yoshihiko Kawaguchi.


Nature Genetics | 1995

Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus

Simon T. Bennett; Anneke Lucassen; S. C. L. Gough; Elizabeth E. Powell; Dag E. Undlien; Lynn E. Pritchard; Marilyn E. Merriman; Yoshihiko Kawaguchi; Mark J Dronsfield; Flemming Pociot; Jørn Nerup; Nourdine Bouzekri; Anne Cambon-Thomsen; Kjersti S. Rønningen; Anthony H. Barnett; S. C. Bain; John A. Todd

The IDDM2 locus encoding susceptibility to type 1 diabetes was mapped previously to a 4.1–kb region spanning the insulin gene and a minisatellite or variable number of tandem repeats (VNTR) locus on human chromosome 11p15.5. By ‘cross–match’ haplotype analysis and linkage disequilibrium mapping, we have mapped the mutation IDDM2 to within the VNTR itself. Other polymorphisms were systematically excluded as primary disease determinants. Transmission of IDDM2 may be influenced by parent–of–origin phenomena. Although we show that the insulin gene is expressed biallelically in the adult pancreas, we present preliminary evidence that the level of transcription in vivo is correlated with allelic variation within the VNTR. Allelic variation at VNTRs may play an important general role in human disease.


Gene | 1998

Cloning of a novel member of the low-density lipoprotein receptor family

Patricia J. Hey; Rebecca C.J. Twells; Michael S. Phillips; Yusuke Nakagawa; Sheryl D. Brown; Yoshihiko Kawaguchi; Roger D. Cox; Guochun Xie; Valarie Dugan; Holly Hammond; Michael L. Metzker; John A. Todd; J. Fred Hess

A gene encoding a novel transmembrane protein was identified by DNA sequence analysis within the insulin-dependent diabetes mellitus (IDDM) locus IDDM4 on chromosome 11q13. Based on its chromosomal position, this gene is a candidate for conferring susceptibility to diabetes. The gene, termed low-density lipoprotein receptor related protein 5 (LRP5), encodes a protein of 1615 amino acids that contains conserved modules which are characteristic of the low-density lipoprotein (LDL) receptor family. These modules include a putative signal peptide for protein export, four epidermal growth factor (EGF) repeats with associated spacer domains, three LDL-receptor (LDLR) repeats, a single transmembrane spanning domain, and a cytoplasmic domain. The encoded protein has a unique organization of EGF and LDLR repeats; therefore, LRP5 likely represents a new category of the LDLR family. Both human and mouse LRP5 cDNAs have been isolated and the encoded mature proteins are 95% identical, indicating a high degree of evolutionary conservation.


Nature Genetics | 1998

A male-female bias in type 1 diabetes and linkage to chromosome Xp in MHC HLA-DR3-positive patients

Francesco Cucca; Juliet V. Goy; Yoshihiko Kawaguchi; Laura Esposito; Marilyn E. Merriman; Amanda Wilson; Heather J. Cordell; Stephen C. Bain; John A. Todd

It is generally assumed that the male:female (M:F) ratio in patients with type 1 (insulin-dependent) diabetes mellitus (IDDM) is 1. A recent survey, however, revealed that high incidence countries (mainly European) have a high M:F ratio and low incidence ones (Asian and African) have a low M:F ratio. We have now analysed the M:F ratio according to genotype at the major locus, the major histocompatibility complex (MHC; IDDM1). There are two main IDDM1 susceptibility haplotypes, HLA-DR3 and -DR4, which are present in 95% of Caucasian cases. We report here that in medium/high incidence Caucasian populations from the United States of America, United Kingdom and Sardinia (1307 cases), the bias in male incidence is largely restricted to the DR3/X category of patients (X ≠ DR4) with a M:F ratio of 1.7 (P = 9.3 × 10–7), compared with a ratio of 1.0 in the DR4/Y category (Y ≠ DR3). This is additional evidence for significant heterogeneity between the aetiology of DR4-associated and DR3-associated diabetes. We analysed linkage of type 1 diabetes to chromosome X, and as expected, most of the linkage to Xp13–p11 was in the DR3/X affected sibpair families (n = 97; peak multipoint MLS at DXS1068 = 3.5, P = 2.7 × 10–4; single point MLS = 4.5, P = 2.7 × 10–5). This is evidence for aetiological heterogeneity at the IDDM1/MHC locus and, therefore, in the search for non-MHC loci in type 1 diabetes, conditioning of linkage data by HLA type is advised.


American Journal of Human Genetics | 1998

Fine Mapping of the Diabetes-Susceptibility Locus, IDDM4, on Chromosome 11q13

Yusuke Nakagawa; Yoshihiko Kawaguchi; Rebecca C.J. Twells; Claire Muxworthy; Kara Hunter; Amanda Wilson; Marilyn E. Merriman; Roger D. Cox; Tony R. Merriman; Francesco Cucca; Patricia A. McKinney; Julian Shield; Jaakko Tuomilehto; Eva Tuomilehto-Wolf; Constantin Ionesco-Tirgoviste; Lorenza Nisticò; Raffaella Buzzetti; Paolo Pozzilli; San-Raffaele Family Study; Geir Joner; Eric Thorsby; Dag E. Undlien; Flemming Pociot; Jørn Nerup; Kjersti S. Rønningen; Stephen C. Bain; John A. Todd

Genomewide linkage studies of type 1 diabetes (or insulin-dependent diabetes mellitus [IDDM]) indicate that several unlinked susceptibility loci can explain the clustering of the disease in families. One such locus has been mapped to chromosome 11q13 (IDDM4). In the present report we have analyzed 707 affected sib pairs, obtaining a peak multipoint maximum LOD score (MLS) of 2.7 (lambda(s)=1.09) with linkage (MLS>=0.7) extending over a 15-cM region. The problem is, therefore, to fine map the locus to permit structural analysis of positional candidate genes. In a two-stage approach, we first scanned the 15-cM linked region for increased or decreased transmission, from heterozygous parents to affected siblings in 340 families, of the three most common alleles of each of 12 microsatellite loci. One of the 36 alleles showed decreased transmission (50% expected, 45.1% observed [P=.02, corrected P=.72]) at marker D11S1917. Analysis of an additional 1,702 families provided further support for negative transmission (48%) of D11S1917 allele 3 to affected offspring and positive transmission (55%) to unaffected siblings (test of heterogeneity P=3x10-4, corrected P=. 01]). A second polymorphic marker, H0570polyA, was isolated from a cosmid clone containing D11S1917, and genotyping of 2,042 families revealed strong linkage disequilibrium between the two markers (15 kb apart), with a specific haplotype, D11S1917*03-H0570polyA*02, showing decreased transmission (46.4%) to affected offspring and increased transmission (56.6%) to unaffected siblings (test of heterogeneity P=1.5x10-6, corrected P=4.3x10-4). These results not only provide sufficient justification for analysis of the gene content of the D11S1917 region for positional candidates but also show that, in the mapping of genes for common multifactorial diseases, analysis of both affected and unaffected siblings is of value and that both predisposing and nonpredisposing alleles should be anticipated.


Annals of Human Genetics | 1995

An extension of the Maximum Lod Score method to X‐linked loci

Heather J. Cordell; Yoshihiko Kawaguchi; John A. Todd; Martin Farrall

The Maximum Lod Score method for affected relative‐pair analysis, introduced by Risch, is a powerful method for detecting linkage between an autosomal marker locus and disease. In order to use the method to detect linkage to markers on the X‐chromosome, some modification is necessary. Here we extend the method to be applicable to X‐chromosomal data, and derive genetic restrictions on the haplotype‐sharing probabilities analogous to the ‘possible triangle’ restrictions described by Holmans for the autosomal case. Size criteria are derived using asymptotic theory and simulation, and the power is calculated for a number of possible underlying models. The method is applied to data from 284 type 1 diabetic families and evidence is found for the presence of one or more diabetogenic loci on the X‐chromosome.


Nature | 1994

A genome-wide search for human type 1 diabetes susceptibility genes.

June L. Davies; Yoshihiko Kawaguchi; Simon T. Bennett; James B. Copeman; Heather J. Cordell; Lynn E. Pritchard; Peter W. Reed; Stephen C. L. Gough; Suzanne C. Jenkins; Sheila M. Palmer; Karen M. Balfour; Beth R. Rowe; Martin Farrall; Anthony H. Barnett; Stephen C. Bain; John A. Todd


Nature Genetics | 1994

Chromosome-specific microsatellite sets for fluorescence-based, semi-automated genome mapping.

Peter W. Reed; June L. Davies; James B. Copeman; Simon T. Bennett; Sheila M. Palmer; Lynn E. Pritchard; S. C. L. Gough; Yoshihiko Kawaguchi; Heather Jane Cordell; Karen M. Balfour; Suzanne C. Jenkins; Elizabeth E. Powell; Alain Vignal; John A. Todd


American Journal of Human Genetics | 1995

Two-locus maximum lod score analysis of a multifactorial trait: joint consideration of IDDM2 and IDDM4 with IDDM1 in type 1 diabetes.

Heather J. Cordell; John A. Todd; Simon T. Bennett; Yoshihiko Kawaguchi; Martin Farrall


Human Molecular Genetics | 1995

Analysis of the CD3 gene region and type 1 diabetes: application of fluorescence-based technology to linkage disequilibrium mapping

Lynn E. Pritchard; Yoshihiko Kawaguchi; Peter W. Reed; James B. Copeman; June L. Davies; Anthony H. Barnett; Stephen C. Bain; John A. Todd


Genomics | 1997

Framework YAC contig anchored into a 3.2-Mb high-resolution physical map in proximal 11q13.

Anouk Courseaux; Pierre Szepetowski; Marie Fernandes; Carine Serizet; Yoshihiko Kawaguchi; Josiane Grosgeorge; Danielle Perucca-Lostanlen; Thomas B. Shows; John A. Todd; Norma J. Nowak; Patrick Gaudray

Collaboration


Dive into the Yoshihiko Kawaguchi's collaboration.

Top Co-Authors

Avatar

John A. Todd

Wellcome Trust Centre for Human Genetics

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Anthony H. Barnett

Heart of England NHS Foundation Trust

View shared research outputs
Top Co-Authors

Avatar

Roger D. Cox

Wellcome Trust Centre for Human Genetics

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

June L. Davies

Wellcome Trust Centre for Human Genetics

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge